I
IDEAYA Biosciences, Inc.
IDYA · NASDAQ · Healthcare · 3.5B
Closing price
$36.11
+0.14% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
3.1×
Enterprise value / EBITDAEV/EBITDA
-20.1×
Free cash flow yieldFCF yield
-2.3%
Return on equityROE
-11.1%
Operating margin
-72.8%
Net debt / EBITDAbalance-sheet strength
0.5×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.